跳至主要内容
临床试验/IRCT2014030116782N1
IRCT2014030116782N1已完成未知

Evaluation of the effect of Panretinal photocoagulation ( PRP ) versus PRP plus Intravitreal Bevacizumab on Macular Thickness, Macular Choroidal Thickness, Peripapillary Nerve Fiber Layer thickness by Optical Coherence Tomography in patients with diabetic retinopathy.

Tehran University Of Medical Sciences, Farabi Hospital, Ophthalmic Research Center0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Presence of severe Nonproliferative diabetic retinopathy or Proliferative diabetic retinopathy in both eyes; Normal intraocular pressure; Refractive error within ±3 diopter (D).
  • Exclusion criteria: Any type of previous retinal treatment ( macular or peripheral laser photocoagulation, vitrectomy, intravitreal steroids and/or antiangiogenic drugs); Glaucoma or ocular hypertension; Significant media opacities that precluded fundus examination or imaging; Other retinal or optic nerve disease; Uncontrolled systemic hypertenion (BP = 180/110); Central macular thickness = 350

排除标准

  • 未提供

研究者

发起方
Tehran University Of Medical Sciences, Farabi Hospital, Ophthalmic Research Center

相似试验

The effect of laser on eye in diabetic patients | 临床试验